CRIS Current Research Information System

RENZULLI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.507
NA - Nord America 7.223
EU - Europa 4.328
AF - Africa 416
Continente sconosciuto - Info sul continente non disponibili 405
SA - Sud America 379
OC - Oceania 13
Totale 20.271
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.073
VN - Vietnam 2.142
SG - Singapore 1.943
CN - Cina 1.771
IT - Italia 1.236
GB - Regno Unito 628
DE - Germania 538
HK - Hong Kong 512
SE - Svezia 466
IN - India 305
BR - Brasile 255
KR - Corea 248
FR - Francia 244
NL - Olanda 229
RU - Federazione Russa 182
IE - Irlanda 179
FI - Finlandia 143
CH - Svizzera 117
JP - Giappone 108
BD - Bangladesh 103
TG - Togo 103
CI - Costa d'Avorio 101
CA - Canada 83
ZA - Sudafrica 81
UA - Ucraina 58
BG - Bulgaria 56
SC - Seychelles 47
ID - Indonesia 46
TH - Thailandia 45
NG - Nigeria 44
JO - Giordania 42
AR - Argentina 41
PH - Filippine 40
PL - Polonia 40
TR - Turchia 39
AT - Austria 36
EE - Estonia 36
MX - Messico 34
PK - Pakistan 28
IQ - Iraq 25
MY - Malesia 25
BE - Belgio 22
TW - Taiwan 22
ES - Italia 19
EC - Ecuador 18
EG - Egitto 18
HR - Croazia 16
CL - Cile 15
CO - Colombia 15
UZ - Uzbekistan 13
LT - Lituania 12
VE - Venezuela 12
GR - Grecia 10
RO - Romania 10
SA - Arabia Saudita 10
AU - Australia 9
CR - Costa Rica 9
PE - Perù 9
HN - Honduras 7
MK - Macedonia 7
JM - Giamaica 6
KE - Kenya 6
PT - Portogallo 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
CZ - Repubblica Ceca 5
PS - Palestinian Territory 5
PY - Paraguay 5
RS - Serbia 5
BO - Bolivia 4
ET - Etiopia 4
HU - Ungheria 4
IR - Iran 4
LV - Lettonia 4
OM - Oman 4
UY - Uruguay 4
KZ - Kazakistan 3
LU - Lussemburgo 3
MA - Marocco 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BY - Bielorussia 2
CG - Congo 2
DK - Danimarca 2
IL - Israele 2
LB - Libano 2
MD - Moldavia 2
NP - Nepal 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
Totale 19.847
Salva come PNG Salva come JPEG
Città #
Singapore 1.416
Ashburn 833
Fairfield 580
Southend 525
Ho Chi Minh City 515
Chandler 511
Hanoi 467
Hong Kong 460
San Jose 448
Hefei 433
Bologna 307
Santa Clara 282
Houston 230
Wilmington 221
Woodbridge 220
Seoul 219
Seattle 212
Beijing 199
Council Bluffs 198
Dublin 179
Boardman 174
Cambridge 167
Los Angeles 165
Princeton 162
Dong Ket 155
New York 130
Milan 116
Lomé 103
Bern 102
Lauterbourg 102
Abidjan 101
Helsinki 97
Ann Arbor 95
Dallas 88
Da Nang 86
Tokyo 86
Munich 85
Haiphong 79
São Paulo 64
Rome 63
Buffalo 61
Sofia 54
Turin 50
Frankfurt am Main 49
The Dalles 48
Berlin 47
Nanjing 45
Westminster 45
Redmond 44
Redondo Beach 44
Bengaluru 43
Amman 42
Abeokuta 41
Florence 41
Bremen 38
Shanghai 38
Guangzhou 37
Johannesburg 35
Orem 35
Amsterdam 34
Padova 31
Jakarta 30
Turku 30
Phoenix 29
San Diego 29
Falkenstein 28
Falls Church 28
Hải Dương 28
Shenyang 28
Atlanta 27
Chicago 27
Des Moines 27
Saint Petersburg 26
San Francisco 26
Warsaw 26
Jinan 25
Changsha 23
Toronto 23
Montreal 22
Tianjin 22
Brussels 21
Washington 21
Nuremberg 20
Tongling 20
Hangzhou 19
London 19
North Bergen 19
Bangkok 18
Jacksonville 18
Redwood City 18
Vienna 18
Can Tho 17
Denver 17
Hyderabad 17
Bắc Ninh 16
Bến Tre 16
Lappeenranta 16
Nanchang 16
Naples 16
Rimini 16
Totale 12.439
Salva come PNG Salva come JPEG
Nome #
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 439
Efficacy of radioembolization according to tumor morphology and portal vein thrombosis inintermediate-advanced hepatocellular carcinoma 315
Monofocal hepatocellular carcinoma: How much does size matter? 302
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 294
A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease 279
Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liver 276
Ablation for hepatocellular carcinoma: beyond the standard indications 272
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 271
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 266
Heterotopic segmental liver transplantation on splenic vessels after splenectomy with delayed native hepatectomy after graft regeneration: A new technique to enhance liver transplantation 266
Prediction of response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed multiple myeloma by gene expression profiling (gep) 256
Machine Learning Pipeline for the Automated Prediction of MicrovascularInvasion in HepatocellularCarcinomas 255
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer 255
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study 251
Diagnostic Accuracy of Cardiac Computed Tomography and 18F-Fluorodeoxyglucose With Positron Emission Tomography in Cardiac Masses 249
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 246
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 246
Pattern of macrovascular invasion in hepatocellular carcinoma 246
SPIOMET4HEALTH—efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial 245
Sarcopenia predicts ascitic decompensation and mortality independently of portal hypertension status in patients with advanced chronic liver disease outside the liver transplantation setting 234
The duration of the conventional chemoembolization for hepatocellular carcinoma: factors affecting the procedural time 230
The changing scenario of hepatocellular carcinoma in Italy: an update 227
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 225
Complete Remission of Advanced Hepatocellular Carcinoma Treated with Sorafenib and Concomitant Appearance of IgG4- related Diseases. A Case Report 225
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 219
Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma 219
Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis 217
Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib 214
Clinical impact of sarcopenia assessment in patients with liver cirrhosis 214
LE PROPRIETÀ NASCOSTE NELL’IMMAGINE RM PER RILEVARE AUTOMATICAMENTE LA ZONA DI TRANSIZIONE TRA CARCINOMA RETTALE LOCALMENTE AVANZATO E TESSUTO SANO, E PREDIRE LA RISPOSTA ALLA TERAPIA NEO-ADIUVANTE 211
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 209
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 208
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 207
Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids of Different Sizes: A Single Center Experience 206
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 203
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 199
Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study 199
Transcatheter Embolization for Giant Splenic Artery Aneurisms: Still an Open Question 199
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging 186
Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma 185
Direct antiviral treatments for hepatitis c virus have off-target effects of oncologic relevance in hepatocellular carcinoma 185
Association between anatomic variations of extrahepatic and intrahepatic bile ducts: Do look up! 184
Liver collision lesion: inflammatory hepatocellular adenoma within focal nodular hyperplasia 184
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 184
COVID-19: Has the Liver Been Spared? 184
MANUALE DI DIAGNOSTICA PER IMMAGINI PER IL CORSO DI LAUREA IN MEDICINA E CHIRURGIA. DIAGNOSTICA PER IMMAGINI DEL FEGATO, DELLA MILZA, DEL PERITONEO E MESENTERE. 2°edizione CAPITOLO 8 - 10 - 13 181
New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: A new diagnostic algorithm 179
The ART Score Is Not Effective to Select Patients for Transarterial Chemoembolization Retreatment in an Italian Series. 178
Definition of local recurrence site in resected pancreatic adenocarcinoma: A multicenter study (dolores-1) 176
Imatinib Mesylate Determines a High Frequency of Major Molecular Responses in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase Chronic Myeloid Leukemia on Behalf of the GIMEMA CML WP. 173
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 170
Automatically Extracted Machine Learning Features from Preoperative CT to Early Predict Microvascular Invasion in HCC: The Role of the Zone of Transition (ZOT) 168
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients 166
From large to small: the immunohistochemical panel in the diagnosis of early hepatocellular carcinoma 165
A Splenic UFO: Intrasplenic Epithelioid Mesothelioma 164
Normothermic and hypothermic oxygenated perfusion for donation after circulatory death in kidney transplantation: Do we pay higher risk of severe infection after transplantation?: A case report 161
Pseudoaneurysm of the splenic artery mimicking a solid lesion 160
Magnetic Resonance Enterography Reinvented: Exploring the Potential of a New Natural Beverage as an Alternative to Polyethylene Glycol Solution 159
TACE performed in patients with a single nodule of Hepatocellular Carcinoma 159
Gastric cancer staging: Is it time for magnetic resonance imaging? 159
Treatment of combined hepatocellular and cholangiocarcinoma 156
Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added Value 156
Sarcopenia predict complications after hepatic resection for primary hepatocellular carcinoma (HCC) in patients with advanced chronic liver disease (ACLD) and clinically significant portal hypertension (CSPH) 155
The interplay between sarcopenia and portal hypertension predicts ascites and mortality in cirrhosis: Sarcopenia predicts ascites and death in cirrhotic patients 155
OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation. 154
Experience with regorafenib in the treatment of hepatocellular carcinoma 154
Large regenerative nodules in a patient with Budd-Chiari syndrome after TIPS positioning while on the liver transplantation list diagnosed by Gd-EOB-DTPA MRI 153
Biliary Variant in a Potential Liver Donor 153
Prognostic Role of Early Cardiac Magnetic Resonance in Myocardial Infarction With Nonobstructive Coronary Arteries 152
Can Current Preoperative Imaging Be Used to Detect Microvascular Invasion of Hepatocellular Carcinoma? 152
Proposal of standardization of every step of angiographic procedure in bleeding patients from pelvic trauma 150
Neuroendocrine pancreatic cancer: diagnosis and characterization with spiral computer tomography and nuclear magnetic resonance. 149
Spleen stiffness measurement predicts the development of primary hepatocellular carcinoma better than hepatic venous pressure gradient 149
Non-invasive diagnosis of clinically significant portal hypertension and treatment with non-selective beta-blockers: a new paradigm 148
Venous outflow in partial heterotopic liver transplantation with spleen replacement: Evidence of no chronic venous hypertension 147
LI-RADS: a great opportunity not to be missed 145
Two surgical techniques are better than one: RAVAS and RAPID are answers for the same issue 143
null 142
Radiological Features of Microvascular Invasion of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease 141
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma 140
Predictive factors for hepatocellular carcinoma recurrence after curative treatments 140
Imaging Software-Based Sarcopenia Assessment in Gastroenterology: Evolution and Clinical Meaning 139
Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure 138
False in Name Only—Gastroduodenal Artery Pseudoaneurysm in a Recurrently Bleeding Patient: Case Report and Literature Review 138
Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions 137
Non-invasive tests for the prediction of primary hepatocellular carcinoma 135
Pathobiological and Radiological Approach For Hepatocellular Carcinoma Subclassification 133
Metronomic capecitabine in patients with hepatocellular carcinoma unresponsive to or ineligible for sorafenib treatment: report of two cases. 132
Pneumatosis intestinalis and spontaneous perforation associated with drug toxicity in oncologic patients: A case series 132
SAT-453-Effects of sorafenib on pancreatic volume and their clinical implications in patients with hepatocellular carcinoma 131
Tumor-associated macrophages and inflammatory microenvironment in gastric cancer: Novel translational implications 127
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients- UEG Week 2020 Poster Presentations 125
Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery 124
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 123
Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma 122
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 121
Contrast-enhanced ultrasound LI-RADS LR-5 in hepatic tuberculosis: Case report and literature review of imaging features 120
Gastric melanoma of unknown primary 119
Non-alcoholic steatohepatitis as a risk factor for intrahepatic cholangiocarcinoma and its prognostic role 118
Outcome of post liver transplant ischemic and non-ischemic biliary stenosis treated with percutaneous interventions:the Bologna experience. 115
Totale 18.667
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.268
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.722 0 34 91 102 169 91 45 138 85 120 569 278
2022/20232.240 166 291 94 287 153 190 104 138 410 61 168 178
2023/2024949 68 127 63 92 98 217 38 70 48 41 60 27
2024/20253.304 173 401 314 254 389 179 293 140 55 289 236 581
2025/20268.220 908 836 626 560 667 369 1.268 251 1.499 581 357 298
2026/2027598 323 275 0 0 0 0 0 0 0 0 0 0
Totale 20.271